Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Diazoxide

Diazoxide

pharmaceutical raw materials
Diazoxide structure

Diazoxide 

structure
  • CAS No:

    364-98-7

  • Formula:

    C8H7ClN2O2S

  • Chemical Name:

    Diazoxide

  • Synonyms:

    2H-1,2,4-Benzothiadiazine,7-chloro-3-methyl-,1,1-dioxide;4H-1,2,4-Benzothiadiazine,7-chloro-3-methyl-,1,1-dioxide;SRG 95213;7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide;Diazoxide;Dizoxide;Hyperstat;3-Methyl-7-chloro-1,2,4-benzothiadiazine 1,1-dioxide;Proglicem;Mutabase;NSC 64198;Eudemine injection;Sch 6783;Hypertonalum;Proglycem;NSC 76130;1342899-70-0

  • Categories:

    Active Pharmaceutical Ingredients  >  Circulatory System Drugs

Description

Diazoxide is an ATP-sensitive potassium channel activator ; can be used to treat hyperinsulinism.


Solid


Diazoxide is a benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies. It has a role as an antihypertensive agent, a sodium channel blocker, a vasodilator agent, a K-ATP channel agonist, a beta-adrenergic agonist, a cardiotonic drug, a bronchodilator agent, a sympathomimetic agent and a diuretic. It is a benzothiadiazine, a sulfone and an organochlorine compound.|A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.|Diazoxide is a benzothiadiazine derivate with antihypertensive and hyperglycemic activities. Diazoxide increases membrane permeability to potassium ions in vascular smooth muscle, thereby stabilizing the membrane action potential and preventing vascular smooth muscle contraction; this results in peripheral vasodilatation and decreases in peripheral vascular resistance. This agent also inhibits insulin release by interacting with ATP-sensitive potassium channels of pancreatic islet beta-cells.

Diazoxide Basic Attributes

230.67

230.67

206-668-1

O5CB12L4FN

759574|76130|64198

DTXSID7022914

C428

C - Cardiovascular system|V - Various

2933990090

Characteristics

66.9

1.2

Solid

1.6±0.1 g/cm3

330.5 °C

414.8°C at 760 mmHg

204.6±29.3 °C

1.692

soluble in 0.1M NaOH. Insoluble in water or in methanol.

Store at RT

8.74None

8.74

143.7 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

Safety Information

NONH for all modes of transport

3

22-36/37/38

22-26-36

DK8185000

Xn

P261-P305 + P351 + P338

H302-H315-H319-H335

|Danger|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P260, P261, P264, P270, P271, P280, P281, P301+P312, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P314, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 88 companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Toxicity

Oral LD50 in rat and mouse: 980 mg/kg and 444 mg/kg, respectively.

Very high (more than 90%) to serum proteins.

Drug Information

Used parentally to treat hypertensive emergencies. Also used to treat hypoglycemia secondary to insulinoma.

Diazoxide is a potassium channel activator. Its mechanism of action revolves around enhancing cell membrane permeability to potassium ions. This action consequently elicits the relaxation of local smooth muscles. This switches off voltage-gated calcium ion channels which inhibits the generation of an action potential.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)|Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)

Readily absorbed following oral administration.|Proglycem is extensively bound (more than 90%) to serum proteins, and is excreted in the kidneys.

Hepatic.

28 ±8.3 hours in normal adults.

Diazoxide inhibits insulin release from the pancreas, by opening potassium channels in the beta cell membrane. Diazoxide is chemically related to thiazide diuretics but does not inhibit carbonic anhydrase and does not have chloriuretic or natriuretic activity. It also exhibits hypotensive activity by reducing arteriolar smooth muscle and vascular resistance.

Diazoxide

Diazoxide Use and Manufacturing

Methods of Manufacturing

Preparation of diazine crude.Take 5-chloro-2-aminobenzenesulfonamide (III) 100g, potassium carbonate 100g, chloroform 600g, Followed by 1L round bottom three-necked flask, Acetyl chloride 80g was added dropwise with stirring at 0 to 10 ° C, Add at room temperature for 6 hours. After the reaction is completed, The reaction solution was poured into 800g of ice water, Slow stirring, Standing, Divided chloroform layer, Concentrate to dryness under reduced pressure.To the resulting oil was added diphenyl ether 400g, The reaction was stirred at 250 ~ 250 for 1 hour, Cool to room temperature, Solid was isolated, washed with ethanol, dry, A pale yellow diazine crude was obtained.(C) Preparation of diazoxide (I).The resulting diazine crude product was recrystallized from 80percent ethanol, Product dry, Smash, Obtained white crystalline powder (sample 3), Diazoxide (I) 85.5 g.The total molar yield is 74.3percent as 5-chloro-2-nitrobenzenesulfonamide.

Uses

Diazoxide reduces status epilepticus neuron damage in diabetes.

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients|Pharmaceuticals

Computed Properties

Molecular Weight:230.67
XLogP3:1.2
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:3
Exact Mass:229.9916763
Monoisotopic Mass:229.9916763
Topological Polar Surface Area:66.9
Heavy Atom Count:14
Complexity:360
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Material

Drug Function and Efficacy

It can relax the smooth muscle of arterioles, dilate blood vessels, reduce peripheral resistance, lower blood pressure, and counteract the vasoconstriction effect of various substances. It can reflexively increase heart rate and cardiac output, while the blood flow of the brain, kidneys, and coronary arteries remains unchanged. It can cause an increase in plasma renin activity, affecting the antihypertensive effect. It can inhibit the secretion of insulin by pancreatic beta cells and increase blood sugar concentration.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • GUANG'AN KINGDAY PHARMA AND CHEM CO LTD

    United States United States
    Active
  • NOVITIUM PHARMA LLC

    United States United States
    Active
  • BIOPHORE INDIA PHARMACEUTICALS PVT LTD

    United States United States
    Active

Recommended Suppliers of Diazoxide

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.